Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

Elaine Mendonca by Elaine Mendonca
January 10, 2024
in Breaking News
0
DVY stock news
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On January 10, 2024, Amarin took a strategic step by entering into a conditional share repurchase agreement with Cantor Fitzgerald. This agreement allows Amarin to repurchase its own ordinary shares, which are held in the form of American depository shares, for an impressive sum of up to $50 million.

Cantor Fitzgerald, a renowned company specializing in providing repurchase agreements to institutional investors, was chosen as the partner for this endeavor. Their expertise in the field ensures a smooth and efficient execution of the share repurchase program.

The announcement of this initiative came shortly after Amarin’s Q4 revenue outlook was disclosed, resulting in a remarkable surge of 16% in the company’s stock value. This positive market response reflects the confidence investors have in Amarin’s future growth and financial stability.

Undoubtedly, the share repurchase agreement with Cantor Fitzgerald holds great significance for Amarin. It not only showcases the company’s strong belief in its own financial position but also demonstrates its unwavering faith in the promising prospects that lie ahead.

Overall, this strategic move by Amarin on January 10, 2024, highlights the company’s commitment to maximizing shareholder value and solidifying its position in the market.

[bs_slider_forecast ticker=”AMRN”]

Amarin Corporation plc (AMRN) Stock Price Surges by 28.34% on January 10, 2024: Positive Momentum and Stability Indicate Potential Investment Opportunity

On January 10, 2024, Amarin Corporation plc (AMRN) experienced a significant surge in its stock price. The stock opened at $1.11, which was $0.14 higher than its previous close. AMRN is currently trading in the middle of its 52-week range, indicating stability over the past year. The stock is also trading above its 200-day simple moving average, suggesting positive momentum. The stock rose by $0.27 since the market last closed, representing a 28.34% rise. The exact reasons behind the surge are not provided, but it may be due to positive news or developments. Investors and analysts will monitor AMRN’s performance to determine if the momentum is sustained. Thorough research and consideration of various factors are important before making investment decisions.

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”AMRN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]

AMRN Stock Performance Plummets in 2024: A Closer Look at Declining Revenue and Net Income

AMRN Stock Performance on January 10, 2024:

On January 10, 2024, Amarin Corporation plc (AMRN) experienced a significant decline in its stock performance, reflecting the company’s financial results for the past year and the third quarter.

Total Revenue:

– Amarin reported a figure of $368.96 million for the past year, which represents a decrease of 36.73% compared to the previous year.
– The company’s total revenue for the third quarter stood at $65.67 million, reflecting a decline of 18.34% since the previous quarter.

Net Income:

– Amarin reported a net loss of -$105.74 million for the past year, representing a staggering decline of 1468.23% compared to the previous year.
– The company’s net loss for the third quarter stood at -$19.20 million, reflecting a decrease of 8.98% since the previous quarter.

Earnings Per Share (EPS):

– Amarin reported an EPS of -$0.26 for the past year, reflecting a decline of 1472.92% compared to the previous year.
– In the third quarter, the company’s EPS stood at -$0.05, representing a decrease of 8.8% since the previous quarter.

Overall, the stock performance of AMRN on January 10, 2024, reflects the company’s challenging financial results for the past year and the third quarter. The significant decreases in total revenue, net income, and earnings per share indicate a difficult period for Amarin. Investors and stakeholders will closely monitor Amarin’s future financial performance as the company seeks to overcome these challenges and regain its financial stability.

Tags: AMRN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Clearmind Medicines Groundbreaking Psychedelic Therapy Shows Promise in Treating Alcohol Use Disorder

Rapid Micro Biosystems Achieves Impressive Financial Milestone

SPAR Group Inc Streamlines Operations and Enhances Value Creation Through Divestiture

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

First Horizon National Stock

Diverging Views Shape First Horizon National’s Investment Narrative

4 weeks ago
Northern Stock

Strategic Moves: Northern Corporation Adjusts Rates and Expands Global Footprint

2 days ago
CME stock news

Navigating Uncertainty: Analysts Provide Mixed Recommendations for Getinge AB amidst Market Volatility

2 years ago
Automotive Stock Market Today

Wealthy Investors Show Negative Outlook on General Motors NYSE GM

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Kratos Defense Secures Coveted Spot in S&P MidCap 400 Index

American Express Doubles Down on Premium Market Strategy

Snowflake Gains Momentum with Leadership Shift and Strategic Alliances

Porsche Holding Faces Perfect Storm as Strategic Shifts and Market Pressures Mount

Replimune Shares Plummet Amid Regulatory Crisis and Mounting Litigation

Dividend Growth and Geopolitical Strain: The Texas Instruments Dilemma

Trending

Anavex Stock
Analysis

Anavex Alzheimer’s Drug: Breakthrough Data Meets Market Skepticism

by Dieter Jaworski
September 22, 2025
0

A clinical-stage biopharmaceutical company has generated significant discussion in Alzheimer's research circles with trial results suggesting unprecedented...

Marsh McLennan Stock

Marsh McLennan Appoints New Leader to Drive International Expansion Strategy

September 22, 2025
Polestar Auto.adr/a Stock

Polestar Faces Mounting Challenges as Recall Compounds Financial Woes

September 22, 2025
Kratos Defense Stock

Kratos Defense Secures Coveted Spot in S&P MidCap 400 Index

September 22, 2025
American Express Stock

American Express Doubles Down on Premium Market Strategy

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Anavex Alzheimer’s Drug: Breakthrough Data Meets Market Skepticism
  • Marsh McLennan Appoints New Leader to Drive International Expansion Strategy
  • Polestar Faces Mounting Challenges as Recall Compounds Financial Woes

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com